Stonin 2 activates lysosomal-mTOR axis for cell survival in oral cancer

Gender-specific association of STON2 rs2371597 polymorphism in keratoconus patients of Saudi origin

Objective

To investigate the association of specific genetic polymorphisms (rs2371597 in STON2, rs11720822 in PDIA5, rs387907358 in WNT1, and rs77542162 in ABCA6) in a Saudi cohort of keratoconus (KC) patients compared to controls.

Methods

A retrospective case-control genetic association study was conducted. The study included 99 KC patients and 193 healthy controls. Genotyping was performed using real-time PCR with TaqMan assays. Associations between genetic polymorphisms and KC were assessed using various genetic models and binary logistic regression analysis.

Results

None of the tested polymorphisms showed an overall association with KC risk. Specifically, the rs2371597 polymorphism in STON2 did not demonstrate a significant association with KC risk across different genetic models. However, a gender-specific effect of rs2371597 was noted: in men, the C/G genotype was associated with a higher risk of KC, particularly in the dominant model, while no significant association was observed in women. Age and sex were identified as significant predictors of KC risk, but rs2371597 did not significantly affect KC risk in regression analysis.

Conclusion

Preliminary evidence suggests a gender-specific effect of the rs2371597 polymorphism in STON2, with an increased KC risk associated with C/G-C/C genotypes in men which was age-dependent. This result highlights the importance of considering population-specific genetic factors and the potential gender-specific effects on KC susceptibility. However, these findings need further validation with larger age- and sex-matched samples of diverse populations.

Profile of key metabolites and identification of HMGCS1-DHEA pathway in porcine Sertoli cells treated by Vitamin C

Vitamin C (Ascorbic acid, AA), as vital micro-nutrient, plays an essential role for male animal reproduction. Previously, we showed that vitamin C reprogrammed the transcriptome and proteome to change phenotypes of porcine immature Sertoli cells (iSCs). Here, we used LC-MS-based non-targeted metabolomics to further investigate the metabolic effects of vitamin C on porcine iSCs. The results identified 43 significantly differential metabolites (DMs) (16 up and 27 down) as induced by vitamin C (L-ascorbic acid 2-phosphate sesquimagnesium salt hydrate, AA2P) treatment of porcine iSCs, which were mainly enriched in steroid related and protein related metabolic pathways. ELISA (Enzyme-Linked ImmunoSorbent Assay) showed that significantly differential metabolites of Dehydroepiandrosterone (DHEA) (involved in steroid hormone biosynthesis) and Desmosterol (involved in steroid degradation) were significantly increased, which were partially consistent with metabolomic results. Further integrative analysis of metabolomics, transcriptomics and proteomics data identified the strong correlation between the key differential metabolite of Dehydroepiandrosterone and 6 differentially expressed genes (DEGs)/proteins (DEPs) (HMGCS1, P4HA1, STON2, LOXL2, EMILIN2 and CCN3). Further experiments validated that HMGCS1 could positively regulate Dehydroepiandrosterone level. These data indicate that vitamin C could modulate the metabolism profile, and HMGCS1-DHEA could be the pathway to mediate effects exerted by vitamin C on porcine iSCs.

Emerging roles of lysosome homeostasis (repair, lysophagy and biogenesis) in cancer progression and therapy

In the era of personalized therapy, precise targeting of subcellular organelles holds great promise for cancer modality. Taking into consideration that lysosome represents the intersection site in numerous endosomal trafficking pathways and their modulation in cancer growth, progression, and resistance against cancer therapies, the lysosome is proposed as an attractive therapeutic target for cancer treatment. Based on the recent advances, the current review provides a comprehensive understanding of molecular mechanisms of lysosome homeostasis under 3R responses: Repair, Removal (lysophagy) and Regeneration of lysosomes. These arms of 3R responses have distinct role in lysosome homeostasis although their interdependency along with switching between the pathways still remain elusive. Recent advances underpinning the crucial role of (1) ESCRT complex dependent/independent repair of lysosome, (2) various Galectins-based sensing and ubiquitination in lysophagy and (3) TFEB/TFE proteins in lysosome regeneration/biogenesis of lysosome are outlined. Later, we also emphasised how these recent advancements may aid in development of phytochemicals and pharmacological agents for targeting lysosomes for efficient cancer therapy. Some of these lysosome targeting agents, which are now at various stages of clinical trials and patents, are also highlighted in this review.